57 PHARMACOLOGICAL INTERVENTION ON SPONTANEOUS OSTEOARTHRITIS IN STR/ORT MICE: EFFECTS OF AGGRECANASE OR COX-2 INHIBITION  by Chiusaroli, R. et al.
Poster Presentations – Animal models S39
Evaluation of the synovial tissue revealed at 15 minutes post-injection
countless numbers of intact RBC that were almost completely disappared
after 48 hours, withonly limited recruitment of macrophages and iron
deposition.
Conclusions: Blood is cleared very rapidly from the canine knee joint, but
in that short time span already has adverse effects on both cartilage and
synovial tissue. This rapid clearance can play a role in the discrepancy
between long-term in vitro and in vivo effects of blood-induced joint
damage since more than 10% v/v blood for 48 hours is needed induced
to long-term adverse effects in vitro. Irrespectively, blood has devastating
effects on articular cartilage very rapidly, and in this respect it is important
to prevent (traumatic) joint haemorrhages and if they occur, to treat them
properly.
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Purpose: Bone morphogenic protein (BMP) activities are controlled in
part by antagonists. In human osteoarthritic (OA) cartilage, the BMP an-
tagonists follistatin and gremlin are increased, but differentially regulated.
Using the OA dog model, we determined if these BMP antagonists were
produced at different stages during the disease process by comparing
their in situ temporal and spatial distribution.
Methods: OA was induced in dogs by sectioning the anterior cruci-
ate ligament. Dogs were sacriﬁced 4 (n = 4), 8 (n = 4), 10 (n = 5) and
12 (n = 4) weeks after surgery, and non-operated (n = 7) dogs served
as normal controls. Cartilage was removed, differentiating ﬁbrillated and
non-ﬁbrillated areas. In situ protein levels of follistatin, gremlin, BMP-2/4
and Il-1b were determined by immunohistochemistry and morphometric
analyses. Growth factor-induced gremlin expression was also assessed
in dog chondrocytes by real-time PCR.
Results: Follistatin and gremlin production was very low in normal carti-
lage. Gremlin was already signiﬁcantly up-regulated in both non-ﬁbrillated
(p< 0.004) and ﬁbrillated (p< 0.02) areas at 4 weeks post-surgery, and
only slightly increased with the progression of the disease. Follistatin
showed a time-dependent increased level in the non-ﬁbrillated areas with
signiﬁcance (p< 0.02) reached at 8−12 weeks; in the ﬁbrillated areas high
levels were already seen at 4 weeks with signiﬁcance reached at each
time point (p< 0.0001). In the whole cartilage, follistatin and Il-1b temporal
production showed similar patterns; this was also true for gremlin and
BMP-2/4, although BMP-2/4 production was already high in the normal
dogs. Data revealed that the basic ﬁbroblast growth factor (bFGF) could
be another factor that increases gremlin early in the disease. Indeed,
bFGF markedly induced gremlin in dog chondrocytes. Moreover, and
although a similar level of bFGF was found in both normal and OA
cartilage, the presence of a marked positive staining in the extracellular
matrix throughout the cartilage layers was found only in the OA cartilage.
Comparison between superﬁcial and deep zones revealed that follistatin
is located mostly in the superﬁcial zone of the cartilage, while gremlin
is produced both in the superﬁcial and deep layers. A similar pattern for
follistatin and Il-1b was found only in the superﬁcial zone, whereas gremlin
and BMP-2/4 had similar proﬁles in both zones.
Conclusions: Data show, for the ﬁrst time, different spatial and temporal
production of gremlin and follistatin in cartilage during the progression
of OA. These data, in addition to the signiﬁcant up-regulation of gremlin
earlier than follistatin, strongly suggest that gremlin is involved during
the early/remodeling phases, and follistatin linked to the inﬂammatory
process of the disease. These ﬁndings may reﬂect different roles for each
antagonist in this disease.
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Purpose: The STR/ort mice develop spontaneous osteoarthritis (OA) of
the knee, and are believed to be a relevant model for human knee OA.
We have recently shown that treatment with glucosamine sulfate reduced
the severity of the OA histological score as well as histomorphometric
parameters in this strain. To further validate this model for drug discovery
purposes, we investigated its responsivity to further interventions believed
to be effective in either murine or human OA. While administration of the
selective Cox-2 inhibitor celecoxib has been shown to be effective on the
symptoms of human OA, it has been recently demonstrated that deletion
of aggrecanase-2 protects mice from cartilage degeneration in surgically-
induced OA. Therefore we investigated in two separate studies the effects
of celecoxib or of a speciﬁc aggrecanase inhibitor (CR 4152), respectively,
in STR/ort mice.
Methods: STR/ort male mice were recruited at 5 months of age
(n = 20−22). One group of animals was sacriﬁced at this age and served
as a “baseline” control. Celecoxib (10 and 30mg/kg b. w.) was admin-
istered orally once daily 3 for months, while CR 4152 (10 and 30mg/kg
of b.w.) was administered subcutaneously once daily for 3 months. At
the end of treatment, the animals were euthanized and the knee joints
collected, processed for histology and blindly scored according to both
Mankin’s and the OARSI method. Furthermore, in the CR 4152 study, a
histomorphometric analysis was performed on the medial tibial plateau,
measuring the parameters of cartilage volume and lesion surface, with
the operator still blinded to the experimental groups. Statistical analysis
was performed by the Student’s t test or by ANOVA followed by Dunn’s
or Dunnett’s tests comparing all treatment groups vs. vehicle.
Results: After three months of daily treatment, we observed that vehicle-
treated animals displayed severe OA with clefting and erosion of the
articular cartilage to the subchondral bone, with prominent chondro-
osseous metaplasias and often inﬂammation and pannus. OA grade ×
stage score of the medial tibial plateau was signiﬁcantly higher in vehicle
vs. naive 5-month (baseline) mice. In the celecoxib 30mg/kg group there
was only a trend for a decrease of the OA grade × stage score that was
far from statistical signiﬁcance (p = 0.648, Figure 1). Conversely, the OA
grade × stage score was signiﬁcantly decreased in the CR 4152 30mg/kg
group compared to vehicle (Figure 2).
Figure 1. OARSI scoring method (grade × stage, median); celecoxib
group.
Figure 2. OARSI scoring method (grade × stage, median); CR 4152
group.
S40 Osteoarthritis and Cartilage Vol. 16 Supplement 4
Histomorphometry showed that following treatment with CR 4152
30mg/kg, articular cartilage volume (Figure 3) increased and the lesion
surface/total surface ratio (Figure 4) decreased signiﬁcantly compared to
vehicle.
Figure 3. Cartilage volume (m3).
Figure 4. Lesion surface/total surface.
Conclusions: Chronic administration of an aggrecanase inhibitor modi-
ﬁed the course of OA in the STR/ort mouse strain, by delaying cartilage
breakdown as assessed histologically and histomorphometrically. Con-
versely a Cox-2 inhibitor at a dose comparable to that used in human
OA, did not produce a statistically signiﬁcant effect. We conclude that OA
in the STR/ort mouse is sensitive to pharmacological intervention, and
therefore this mouse strain can be useful as a model for drug discovery
processes.
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Purpose: Although subchondral bone changes are evidently part of
osteoarthritis the underlying pathophysiology of these changes and their
relation to cartilage damage are still unclear. The aim of the present study
was to add to the understanding of the role of subchondral bone changes
in the process of OA by relating changes in subchondral bone to cartilage
degeneration in two canine models of OA.
Methods: Experimental OA was induced bilaterally according to the
canine ACLT and Groove model (Intema et al, J Orthop res 2008);
bilateral sham surgery served as a control. At 20 weeks post surgery,
the subchondral plate and epiphyseal trabecular bone of the tibia were
analyzed by micro-CT. These bone changes were related to changes in
cartilage. Metaphyseal trabecular bone changes served as a reference.
Results: Macroscopic, histological and biochemical cartilage analysis
demonstrated statistically signiﬁcant characteristic features of OA, similar
for the ACLT and Groove model, although slightly more outspoken for
the Groove model. Interestingly, subchondral trabecular bone changes
characteristic of early OA such as a decrease in bone volume fraction
(BVTV; −31%; p< 0.05), increase in structural model index (SMI; 1.4;
p< 0.05) and decrease in trabecular thickness (TbTh; −25%; p< 0.05)
were observed in the ACLT model, but hardly in the Groove model
(−6%, +0.2 and −5% respectively; all ns). Thus, these changes did not
correlate with cartilage changes. In contrast trabecular characteristics of
subchondral bone correlated well with those of metaphyseal bone (BVTV:
R=0.364, p = 0.137; SMI: R=0.742, p = 0.00; TbTh: R=0.839, p = 0.00),
suggesting a role for a changed loading pattern. Remarkably, in both
models, a thinning of the subchondral plate was found that correlated
well with parameters of cartilage damage such as proteoglycan content
(R=0.522; p = 0.026), suggesting that subchondral plate adaptation is
part of the osteoarthritic etiological process.
Conclusions: The absence of a correlation between changes in cartilage
and subchondral trabecular bone suggests that these bone changes and
cartilage damage can be differentially regulated in the process of OA.
Subchondral trabecular bone changes can be the result of unloading
while changes in subchondral plate thickness seem more related to the
cartilage changes.
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Purpose: Extrapolation to human osteoarthritis (OA) is the main objective
in the majority of studies using experimental models of OA. Surprisingly, a
comparison of biochemical characteristics of human and experimental OA
is hardly seen. The canine Groove model of OA is based on a temporary
trigger; chondral mechanical damage, and can be a very suitable model
for testing treatment strategies or studying features of human OA. In the
present study, cartilage changes in the Groove model were compared to
those found in human OA.
Methods: In 23 Beagle dogs, OA was induced according to the Groove
model (Marijnissen et al, Osteoarthritis Cartilage 2002; Mastbergen et al,
Osteoarthritis Cartilage 2006). Grooves are surgically applied to the
femoral condyles followed by temporary intensiﬁed loading of the knee
joint. The contra-lateral joint was used as a control. For comparison, knee
cartilage was obtained from 27 human donors, 14 with clinically deﬁned
OA (joint replacement surgery) and 13 with normal healthy cartilage (post-
mortem). Note that only full thickness, although severely degenerated,
cartilage was used. In fact, the total joint frequently contained signiﬁcant
areas of eburnated bone. Ex-vivo biochemical and histological character-
istics of cartilage in the Groove model were compared to those of human
cartilage.
Results: When comparing the Groove model to human osteoarthritis,
characteristic changes in cartilage matrix integrity, compared to their
respective controls were similar. Proteoglycan (PG) content decreased
by 17% for human OA and 15% for the Groove model. Changes in
chondrocyte activity, represented by an increased PG synthesis (+100%
for human OA, +70% for the Groove model), enhanced PG release
(+4.8% for human OA, +5.0% for the Groove model) and an enhanced
newly formed PG release (+7.7% for human OA, +4.6% for the Groove
model) were comparable in both models. Histological analysis corrobo-
rated the biochemical ﬁndings: an increase of 3.8 points for human OA
and 2.4 points for the Groove model according to the modiﬁed Mankin
score.
Conclusions: For the ﬁrst time it is been demonstrated that the canine
Groove model of OA has cartilage characteristics highly comparable to
human OA, cartilage obtained from patients undergoing total knee re-
placement surgery. This is reﬂected in changes of proteoglycan turnover,
proteoglycan content, and histological changes. This adds to the value of
the Groove model as an experimental model for human OA.
